glp-1 weight regain after stopping receptor agonists | Gustavo Monnerat posted on the topic Trajectory of the body weight

In the above animal model, cotadutide administration was associated with reduction of hepatic inflammation and fibrosis, as indicated by decreases in quantitative measures of liver fibrosis, circulating collagen markers, and inflammatory/pro-fibrotic genes [39]

Chronic adolescent exposure to -9-tetrahydrocannabinol in COMT mutant mice: impact on psychosis-related and other phenotypes

Research has explored its potential interactions with cortisol and luteinizing hormone (LH) secretion, as well as its activity on opioid receptor pathways and antioxidant mechanisms at the cellular level, making it a versatile subject across neuroscience, endocrinology, and oxidative stress research models

Both are valid

When the middleman gets removed, the drug does not change